Description: ContextVision AB (publ), a medical technology software company, provides image analysis and artificial intelligence software solutions to original equipment manufacturers in Asia, Europe, and the United States. The company offers image enhancement software for 2D/3D/4D ultrasound, radiography, magnetic resonance imaging (MRI), and mammography. Its products include Rivent that offers unparalleled image quality for various types of ultrasound systems for women's health, general imaging, cardiovascular, and point of care applications; VolarView, an image enhancement software for the handheld ultrasound market segment; and GOPiCE, a technology for volumetric image enhancement in real-time. The company also provides Altumira/Altumira Plus, a platform for digital radiography; and Orthopedic Package for orthopedic imaging. In addition, it offers GOPView MRI2Plus, an image enhancement solution for MRI; and INIFY Prostate Screening for digital analysis of prostate biopsies. The company was founded in 1983 and is headquartered in Stockholm, Sweden.
Home Page: www.contextvision.com
HollAendargatan 13, 2 tr
Stockholm,
111 36
Sweden
Phone:
46 87 50 35 50
Officers
| Name | Title |
|---|---|
| Mr. Gerald Potzsch | Chief Exec. Officer |
| Mr. Markus Hokerberg | Chief Financial Officer |
| Mr. Gunnar Lathen | Chief Technology Officer |
| Mr. Ola Lindblad | Chief Sales & Solution Officer |
| Ms. Karin Lindbom | Interim Chief HR Officer |
| Ms. Ann-Charlotte Linderoth | Exec. Officer |
| Ms. Ann-Sofi Hoff | Chief Product Officer |
| Ms. Katarina Flood | Chief Service Officer |
| Ms. Marilyn M. Bui M.D., Ph.D. | DPA Pres, Pathologist, Lab director & Fellowship Program Director at Moffitt cancer Center |
Exchange: OL
Country: NO
Currency: Norwegian Krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 21.3333 |
| Price-to-Book MRQ: | 12.6087 |
| Price-to-Sales TTM: | 6.6116 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 33 |